PDS Biotechnology trades 1,291 contracts. The company has the following event: Key Opinion Leader (KOL) Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases on Oct 15, 2026.
PDS Biotechnology trades 1,849 contracts. The company has the following event: Key Opinion Leader (KOL) Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases on Oct 15, 2026.
PDS Biotechnology trades 5,686 contracts. The company has the following event: Key Opinion Leader (KOL) Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases on Oct 15, 2026.
